Abstract
Circulating tumor DNA (ctDNA) is a promising resource to detect and monitor molecular characteristics of tumors. In the present study, we precisely determined mutational status of plasma ctDNA in patients with genitourinary (GU) cancers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have